PERFORMANCE / SINGLE
TESAMORELIN
5MG · 10MG · 20MGThis content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.
Research Overview
A synthetic analogue of growth-hormone-releasing hormone (GHRH), studied for its ability to stimulate pulsatile pituitary GH release and downstream IGF-1 elevation.
Available Strengths
- 5MG (TSM5)
- 10MG (TSM10)
- 20MG (TSM20)
Research Protocol
Reference titration schedule
| Period | Dose | U-100 units | Volume |
|---|---|---|---|
| Week 1 | 1 mg | 50 | 0.5 mL |
| Week 2+ | 2 mg | 100 | 1 mL |
Reconstitution
2.0 mg/mL once reconstituted
- Draw 2.5 mL of bacteriostatic water per 5 mg vial.
- Inject slowly along the vial wall; swirl gently until dissolved. Do not shake.
- Label the preparation date and store refrigerated.
Research context
Binds pituitary GHRH receptors, prompting pulsatile growth-hormone secretion; the resulting IGF-1 rise is studied in lipolysis and protein-synthesis research.
Storage
2–8°C (or 20–25°C for some formulations), protected from light. 2–8°C, use within 7 days, avoid freeze-thaw cycles.
Research Notes
- For educational and research reference only. Not medical advice and not intended for unsupervised human use.
References
Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source